These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2979064)

  • 1. Synthesis and testing of antibody-antifolate conjugates for drug targeting.
    Ghose T; Blair AH; Kralovec J; Mammen M; Uadia PO
    Targeted Diagn Ther; 1988; 1():81-122. PubMed ID: 2979064
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibody-mediated targeting of alkylating agents for the treatment of cancer.
    Smyth MJ; Pietersz GA; Farquhar I; McKenzie C
    Targeted Diagn Ther; 1988; 1():123-56. PubMed ID: 2979055
    [No Abstract]   [Full Text] [Related]  

  • 3. KS1/4-DAVLB, a monoclonal antibody-vinca alkaloid conjugate for site-directed therapy of epithelial malignancies.
    Bumol TF; Baker AL; Andrews EL; DeHerdt SV; Briggs SL; Spearman ME; Apelgren LD
    Targeted Diagn Ther; 1988; 1():55-79. PubMed ID: 2979063
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biodistribution of monoclonal antibody and Fab fragment and antitumor effect of their conjugates on hepatoma xenografts].
    Li J; Zhen Y; Yang Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Oct; 16(5):328-33. PubMed ID: 7720121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific prodrug activation by antibody-beta-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models.
    Meyer DL; Jungheim LN; Law KL; Mikolajczyk SD; Shepherd TA; Mackensen DG; Briggs SL; Starling JJ
    Cancer Res; 1993 Sep; 53(17):3956-63. PubMed ID: 8358723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of antifolate resistance.
    Assaraf YG
    Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved tumor targeting with chemically cross-linked recombinant antibody fragments.
    King DJ; Turner A; Farnsworth AP; Adair JR; Owens RJ; Pedley RB; Baldock D; Proudfoot KA; Lawson AD; Beeley NR
    Cancer Res; 1994 Dec; 54(23):6176-85. PubMed ID: 7954464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates.
    Byers VS; Pimm MV; Scannon PJ; Pawluczyk I; Baldwin RW
    Cancer Res; 1987 Oct; 47(19):5042-6. PubMed ID: 3497715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunotoxin: from the idea of "magic bullets" to clinical applications].
    Engert A; Thorpe P
    Med Klin (Munich); 1990 Sep; 85(9):555-60. PubMed ID: 2233614
    [No Abstract]   [Full Text] [Related]  

  • 11. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
    Ojima I
    Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1985 May; 69(5):551-3. PubMed ID: 4005878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma.
    Teicher BA; Alvarez E; Liu P; Lu K; Menon K; Dempsey J; Schultz RM
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):55-62. PubMed ID: 10598556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activity of tricyclic antifolate compounds with fixed geometry.
    Rosowsky A; Modest EJ
    Ann N Y Acad Sci; 1971 Nov; 186():258-69. PubMed ID: 5002300
    [No Abstract]   [Full Text] [Related]  

  • 15. [Folic acid antagonists pemetrexed].
    Heinzl S
    Med Monatsschr Pharm; 2004 Jul; 27(7):220-2. PubMed ID: 15296355
    [No Abstract]   [Full Text] [Related]  

  • 16. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposome and adriamycin].
    Li WJ; Qian HN; Lu WY
    Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):296-8, 319. PubMed ID: 7956556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular aspects of folate and antifolate membrane transport.
    Brzezińska A; Wińska P; Balińska M
    Acta Biochim Pol; 2000; 47(3):735-49. PubMed ID: 11310973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increased effect of neocarzinostatin bound to chimeric Fab fragments of monoclonal antibody A7 on the proliferation of human pancreatic carcinoma].
    Otsuji E; Kobayashi S; Nishida T; Yamamoto K; Matsumura H; Ichikawa D; Okamoto K; Shirasu M; Sakakura C; Kitamura K; Yamaguchi T
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1775-7. PubMed ID: 9757206
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutational 'hot-spots' in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: sequence and structural comparison.
    Volpato JP; Pelletier JN
    Drug Resist Updat; 2009; 12(1-2):28-41. PubMed ID: 19272832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eventual oncostatic action of a chemotherapeutic agent with antifolic acid mechanism].
    La Pesa M; Grimaldi T; Curci E; Semeraro N
    Pathologica; 1971; 63(917):93-6. PubMed ID: 5142408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.